Leap Therapeutics Inc Working Capital to Net Assets Ratio
Leap Therapeutics Inc working capital to net assets ratio. Leap Therapeutics Inc (LPTX) has a Working Capital to Net Assets ratio of 66.6% as of September 2025. Working capital of $1.79 Million (current assets of $10.50 Million minus current liabilities of $8.70 Million) is measured against net assets of $2.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Leap Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Leap Therapeutics Inc (2012–2024)
Working capital to net assets ratio of Leap Therapeutics Inc from 2012 to 2024. This chart shows how Leap Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 66.6%, reflecting working capital of $1.79 Million against net assets of $2.69 Million USD. See Leap Therapeutics Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Leap Therapeutics Inc Working Capital to Net Assets Ratio by Year (2012–2024)
Leap Therapeutics Inc working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Leap Therapeutics Inc from 2012 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Leap Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 96.9% | $33.96 Million | $35.05 Million | $48.04 Million | $14.08 Million | ▼ -1.1 pp |
| 2023 | 98.0% | $58.91 Million | $60.14 Million | $71.60 Million | $12.68 Million | ▲ +6.3 pp |
| 2022 | 91.7% | $50.10 Million | $54.64 Million | $53.22 Million | $3.12 Million | ▼ -7.4 pp |
| 2021 | 99.1% | $106.89 Million | $107.89 Million | $116.87 Million | $9.99 Million | ▲ +1.9 pp |
| 2020 | 97.2% | $65.50 Million | $67.41 Million | $67.30 Million | $1.80 Million | ▼ -145.5 pp |
| 2019 | 242.7% | $-4.25 Million | $-1.75 Million | $4.24 Million | $8.49 Million | ▲ +124.2 pp |
| 2018 | 118.5% | $10.87 Million | $9.18 Million | $17.32 Million | $6.45 Million | ▼ -75.6 pp |
| 2017 | 194.1% | $21.57 Million | $11.12 Million | $27.66 Million | $6.08 Million | ▲ +94.9 pp |
| 2015 | 99.1% | $26.64 Million | $26.87 Million | $27.92 Million | $1.28 Million | ▲ +3.4 pp |
| 2014 | 95.7% | $44.23 Million | $46.21 Million | $46.72 Million | $2.49 Million | ▲ +2.0 pp |
| 2013 | 93.7% | $17.59 Million | $18.77 Million | $19.56 Million | $1.97 Million | ▼ -17.1 pp |
| 2012 | 110.8% | $14.51 Million | $13.10 Million | $16.01 Million | $1.50 Million | — |